| Date | Title and Summary | Additional Formats |
|---|---|---|
| Conatus Pharmaceuticals Announces Upcoming Oral Presentation at EASL Annual Meeting | View HTML
PDF Version
|
|
| Conatus Pharmaceuticals Announces Top-line Results from Phase 2b POLT-HCV-SVR Clinical Trial | View HTML
PDF Version
|
|
| Conatus Pharmaceuticals Reports 2017 Financial Results and Program Updates | View HTML
PDF Version
|
|
| Conatus Pharmaceuticals to Highlight Anticipated Clinical Data Readouts at Upcoming Investor Conferences | View HTML
PDF Version
|
|
| Conatus Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results | View HTML
PDF Version
|
|
| Conatus Pharmaceuticals to Host Expert Call on Unmet Need in HCV-SVR Patients | View HTML
PDF Version
|
|
| Conatus Pharmaceuticals to Highlight Anticipated Clinical Data Readouts and Strategic Initiatives at Upcoming Investor Events | View HTML
PDF Version
|
|
| Conatus to Present at Stifel Healthcare Conference | View HTML
PDF Version |
|
| Conatus Pharmaceuticals Reports Third Quarter 2017 Financial Results and Program Updates | View HTML
PDF Version
|
|
| Conatus Pharmaceuticals to Report Third Quarter 2017 Financial Results | View HTML
PDF Version |
